Theralase just announced a non brokered private placement.  The announcement specified the closing date of the offering, the price of the shares with an attached warrant, the price of when the warrant is in the money, and how much they hope to raise.  Specific, straightforward language.  Why couldn't Poet do that and avoided dropping the share price from $4.00 to as low as $1.50 and the ensuing margin calls that hurt loyal shareholders. ?  Amateur hour !  We deserved to be treated better than that and this has cost them trust that maybe hard to ever recover from. Considering they pulled the same thing in 2016 this shouldn't have been a surprise as to what would happen.